Uterine leiomyoma. Leiomyoma of uterus, unspecified
Conditions
Interventions
Intervention 1: Intervention group: will receive 50,000 weekly dose of Pearl Vitamin D in addition to medical treatment of uterine leiomyoma for 8 weeks. Intervention 2: Control group: will receive a
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
15 Years to 49 Years
Inclusion criteria
Inclusion criteria: Age between 15-49 years At least existence of one confirmed uterine leiomyoma in the ultrasound without need of surgery Existence of uterine leiomyoma symptoms in history Under medical treatment of uterine leiomyoma 25 hydroxy vitamin D values less than 30 ng/ml
Exclusion criteria
Exclusion criteria: Pathology existence of the uterus, ovaries and adnexes in sonography Existence of contraindication for vitamin D intake Existence of any chronic medical condition Pregnancy or desire to become pregnant within the next 6 months and lactation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: Before, 2 and 4 months after intervention. Method of measurement: Uterine Fibroid Symptom & Health-Related Quality Of Life Questionnaire.;Uterine Fibroid Symptom. Timepoint: Before, 2 and 4 months after intervention. Method of measurement: Uterine Fibroid Symptom & Health-Related Quality Of Life Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum concentration of 25-hydroxy vitamin D3. Timepoint: Before and 4 months after intervention. Method of measurement: Elisa test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSamira Noorzaie
Tehran University of Medical Sciences
Outcome results
None listed